Skip to content
OpenCapital
Get started

Zimmer Biomet Holdings ZBH Q1 2026 earnings

Reported April 28, 2026 · Before market open

Revenue$2.1BBeat by $16.2MDiluted EPS$2.09Beat by $0.23
Revenue estimate$2.1B
EPS estimate$1.86

Next report

Aug 6, 2026 (In 3 weeks)
Revenue estimate$2.1B
EPS estimate$2.01

Financials

Q1 2026

Income statement

See full
Revenue$2.1B+9.3%
Gross profit$1.5B+11.1%
Operating income$373.2M+27.7%
Net income$238.1M+30.8%
EPS (diluted)$1.22+34.1%

Balance sheet

See full
Cash & equivalents$424.2M-69.4%
Total debt$7.5B+4.1%
Total equity$12.7B+2.2%
Total assets$22.7B+2.4%

Cash flow

See full
Operating cash flow$359.4M-6.1%
CapEx$36.3M-18.6%
Free cash flow$323.1M-4.5%

Valuation & ratios

Valuation

as of 07/09/26
See full
Market cap$16.94B-21.5%
Enterprise value$23.99B-12.7%
P/E22.3×-1.4×
P/S2×-0.8×

Profitability

See full
Gross margin70%-1.0pp
Operating margin14%-3.0pp
Net margin9.1%-2.8pp
FCF margin17.3%-1.6pp

Returns & leverage

See full
Return on equity6.1%-1.2pp
Debt / equity0.6×0.0×
Current ratio1.7×-0.7×

Segments

By product

See full
Knees$828.6M+4.5%
SET$562.2M+19.5%
Hips$524.1M+5.7%
Technology And Data Bone Cement And Surgical$171.8M+14.6%

By geography

See full
Americas$1.3B+9.7%
EMEA$489.9M+10.9%
Asia Pacific$272.3M+4.5%

Versus estimates

Revenue

Q1 2026$2.1BBeat by $16.2M
Q4 2025$2.2BBeat by $19.9MQ3 2025$2.0BMiss by $10.4MQ2 2025$2.1BBeat by $20.5MQ1 2025$1.9BBeat by $13.9MQ4 2024$2.0BBeat by $8.9M

Diluted EPS

Q1 2026$2.09Beat by $0.23
Q4 2025$2.42Beat by $0.04Q3 2025$1.90Beat by $0.03Q2 2025$2.07Beat by $0.09Q1 2025$1.81Beat by $0.04Q4 2024$2.31Beat by $0.01

Ask the moment Zimmer Biomet Holdings reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Zimmer Biomet Holdings report Q1 2026 earnings?
Zimmer Biomet Holdings (ZBH) reported Q1 2026 earnings on April 28, 2026 before market open.
What were Zimmer Biomet Holdings's Q1 2026 revenue and EPS?
Zimmer Biomet Holdings reported revenue of $2.1B and diluted EPS of $2.09 for Q1 2026.
Did Zimmer Biomet Holdings beat estimates in Q1 2026?
Revenue beat the consensus estimate of $2.1B by $16.2M. EPS beat the consensus estimate of $1.86 by $0.23.
How did Zimmer Biomet Holdings's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 9.3% from $1.9B a year earlier and diluted EPS grew 15.5% from $1.81.
Where can I find Zimmer Biomet Holdings's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-183411) and the 10-Q periodic report (0001193125-26-201710) directly on SEC EDGAR. The filing index links above go to sec.gov.